147 related articles for article (PubMed ID: 38478260)
1. HELLS Knockdown Inhibits the Malignant Progression of Lung Adenocarcinoma Via Blocking Akt/CREB Pathway by Downregulating KIF11.
Yang G; Fu J; Wang J; Ding M
Mol Biotechnol; 2024 Mar; ():. PubMed ID: 38478260
[TBL] [Abstract][Full Text] [Related]
2. LncRNA VPS9D1-AS1 Promotes Malignant Progression of Lung Adenocarcinoma by Targeting miRNA-30a-5p/KIF11 Axis.
Liu J; Feng Y; Zeng X; He M; Gong Y; Liu Y
Front Genet; 2021; 12():807628. PubMed ID: 35140744
[No Abstract] [Full Text] [Related]
3. KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer.
Zhou J; Chen WR; Yang LC; Wang J; Sun JY; Zhang WW; He ZY; Wu SG
Cancer Res Treat; 2019 Jul; 51(3):1207-1221. PubMed ID: 30590004
[TBL] [Abstract][Full Text] [Related]
4. KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma.
Li Z; Yu B; Qi F; Li F
Front Oncol; 2021; 11():670218. PubMed ID: 33968780
[TBL] [Abstract][Full Text] [Related]
5. Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway.
Chen X; Zhang W; Xu X
World J Surg Oncol; 2021 Aug; 19(1):232. PubMed ID: 34362378
[TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells.
Sakuma Y; Hirai S; Sumi T; Niki T; Yamaguchi M
Biochem Biophys Res Commun; 2023 Oct; 678():84-89. PubMed ID: 37619315
[TBL] [Abstract][Full Text] [Related]
7. ASPM combined with KIF11 promotes the malignant progression of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
Wu B; Hu C; Kong L
Exp Ther Med; 2021 Oct; 22(4):1154. PubMed ID: 34504599
[TBL] [Abstract][Full Text] [Related]
8. TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.
Wang J; Pan X; Li J; Zhao J
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35485284
[TBL] [Abstract][Full Text] [Related]
9. Silencing of
An W; Yu F
Open Med (Wars); 2022; 17(1):1655-1663. PubMed ID: 36349192
[TBL] [Abstract][Full Text] [Related]
10. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.
Chen L; Hu K; Liu Y; Liu L; Tang J; Qin X
Drug Dev Res; 2022 Nov; 83(7):1589-1599. PubMed ID: 35903032
[TBL] [Abstract][Full Text] [Related]
12. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
Wang Y; Mei X; Song W; Wang C; Qiu X
BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
[TBL] [Abstract][Full Text] [Related]
13. HSPE1 enhances aerobic glycolysis to promote progression of lung adenocarcinoma.
Xie T; Li M
Mutat Res; 2024 Jun; 829():111867. PubMed ID: 38878504
[TBL] [Abstract][Full Text] [Related]
14. C1orf74 positively regulates the EGFR/AKT/mTORC1 signaling in lung adenocarcinoma cells.
Guo J; Li A; Guo R; He Q; Wu Y; Gou Y; Jin J; Huang G
PeerJ; 2022; 10():e13908. PubMed ID: 36032960
[TBL] [Abstract][Full Text] [Related]
15. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
16.
Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
Front Oncol; 2021; 11():754290. PubMed ID: 34745988
[TBL] [Abstract][Full Text] [Related]
17. Centromere protein N promotes lung adenocarcinoma progression by activating PI3K/AKT signaling pathway.
Zheng Y; You H; Duan J; Chen B; Wu C; Chen P; Wang M
Genes Genomics; 2022 Sep; 44(9):1039-1049. PubMed ID: 35150399
[TBL] [Abstract][Full Text] [Related]
18. [miR-218-5p Targeting TPX2 Regulates p53 Pathway and Inhibits Malignant Progression of Lung Adenocarcinoma].
Xu J
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):721-731. PubMed ID: 37989335
[TBL] [Abstract][Full Text] [Related]
19. SOX9 promotes the invasion and migration of lung adenocarcinoma cells by activating the RAP1 signaling pathway.
Yang JF; Liao Q; Lu CL
BMC Pulm Med; 2023 Nov; 23(1):421. PubMed ID: 37919693
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells.
Kang H; Ma D; Zhang J; Zhao J; Yang M
BMC Pulm Med; 2021 May; 21(1):166. PubMed ID: 33992085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
